Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
-

-

-
-
-
-
 
WKN: A2QLBW / Symbol: ACOR / Name: Acorda Therapeut / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Acorda Therapeutics Cdt Stock

Pros and Cons of Acorda Therapeutics Cdt in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
C******** o* t** e**********
?
S********** s********
Cons
?
B****
?
G***** c******* t* c**********
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Acorda Therapeutics Cdt vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Acorda Therapeutics Cdt - - - - - - -
Salarius Pharmaceuticals Inc. 1.470% -21.538% -20.000% -76.920% -26.486% -98.684% -99.992%
Ardelyx Inc. 0.000% -3.641% -22.870% 71.742% 19.031% 28.024% -
Evolus Inc 0.770% 1.563% -2.985% 66.667% 39.037% 31.287% -

Comments

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
Show more

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
Show more

Acorda Therapeutics, Inc. (NASDAQ: ACOR) is now covered by analysts at StockNews.com. They set a "buy" rating on the stock.
Ratings data for ACOR provided by MarketBeat
Show more